Clinical Benebit of CDK Inhibitors in the Late-line Treatment of Metastatic Breast Cancer: a Case Report
Matsui Chise, Tetsuro Yamane(Kyoto Prefectural University of Medicine), Hiroyuki Tada(Tohoku University), Masahide Yamaguchi(Matsushita Memorial Hospital), Shogen Boku(Kyoto Prefectural University of Medicine), Hiroki Takeshita(Matsushita Memorial Hospital), Hiromichi Ishii(Matsushita Memorial Hospital), Hiroshi Arakawa, Akinori Noguchi(Matsushita Memorial Hospital), Ito Tadao, Naoki Tani(Osaka Gakuin University), Hiroyuki Izumi(Yokohama National University), Mika Kanayama
京都府立医科大学雑誌
January 1, 2020
Cited by 0
Related Papers
PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria
|Nature Communications|2012|599
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
|The Lancet|2014|436
MEIOSIN Directs the Switch from Mitosis to Meiosis in Mammalian Germ Cells
|Developmental Cell|2020|211